TELA CIK: 1561921

TELA Bio, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
59.1
FY22:
62.4
FY23:
71.7
FY24:
78.1
FY25:
75.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.49
FY22:
5.41
FY23:
6.32
FY24:
8.50
FY25:
5.84
Total assets
Change from FY21 to FY25
millions USD
FY21:
62.5
FY22:
67.9
FY23:
78.0
FY24:
86.6
FY25:
81.4

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
10.6
FY22:
12.4
FY23:
17.0
FY24:
15.6
FY25:
18.0
(negative)
Change from FY21 to FY25
millions USD
FY21:
31.9
FY22:
41.1
FY23:
42.2
FY24:
42.5
FY25:
57.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
20.1
FY22:
14.3
FY23:
18.9
FY24:
28.5
FY25:
6.31
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
62.5
FY22:
67.9
FY23:
78.0
FY24:
86.6
FY25:
81.4

All amounts in millions USD Data source:SEC EDGAR